About 3Xper Innoventure Limited
Data last updated:
3Xper Innoventure Limited is a public limited company based in Chennai, Tamil Nadu, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 12 May 2023.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U21001TN2023PLC160370. Its GSTIN is 37AACCZ1929L1ZV (Andhra Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹300 Cr and a paid-up capital of ₹300 Cr. It is led by directors including Govindarajan Narayanan (Whole-Time Director) and Annamalai Meyyappan (Individual Subscriber).
Its last annual general meeting (AGM) was held on 21 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.46 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹42.74 Cr and EBITDA of -₹36.2 Cr.
The company has about 55 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: 3xper Innoventure. As per MCA filings, the company has open charges of ₹75 Cr on record. The company has 5 deals on record (4 funding rounds, 1 rights issue), with disclosed funding of ₹125 Cr; the latest was in September 2024.
For more details, the company can be reached via its website 3xper.com.
Company details
Contact details
3Xper Innoventure Limited's registered office is in Chennai, Tamil Nadu.
- Social Media
- Registered AddressChola Crest C54 – 55 & Super B – 4, Thiru – VI – Ka Industrial Estate Guindy, Chennai, Tamil Nadu, India – 600032
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
3Xper Innoventure operates one associated brand: 3xper Innoventure. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers contract research, development, and manufacturing for pharma and biotech companies. | 3xper.com |
Business activity
The main business activity of 3Xper Innoventure is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of 3Xper Innoventure Limited, buy the company report.
Financials of 3Xper Innoventure Limited
FY 2025 filings available3Xper Innoventure Limited reported revenue of ₹6.46 Cr (up 400% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 400% in the latest year. EBITDA fell 169% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹36.2 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹42.74 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of 3Xper Innoventure Limited, buy the company report.
Board of directors of 3Xper Innoventure Limited
3Xper Innoventure has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Govindarajan Narayanan | Whole-Time Director | 12 May 2023 | 3 Years 5 Months | Current |
| Annamalai Meyyappan Also directs: 3Xper Innoventure Labs Limited, Ti Medical Private Limited, Moshine Electronics Private Limited and 3 more | Individual Subscriber | 12 May 2023 | 3 Years 5 Months | Current |
| Mukesh Ahuja Also directs: Tube Investments of India Limited, Ti Clean Mobility Private Limited, Shanthi Gears Limited and 5 more | Director | 12 May 2023 | 3 Years 5 Months | Current |
| Srinivasan Krithika | Individual Subscriber | 12 May 2023 | 3 Years 5 Months | Current |
| Vellayan Subbiah Also directs: SRF Limited, Tube Investments of India Limited, Cholamandalam Financial Holdings Limited and 5 more | Director | 12 May 2023 | 3 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Jul 2024 | 100944380 | The Hongkong and Shanghai Banking Corporation Limited | ₹75 Cr | Open |
Total charge records: 1 View all charges
Deals & funding
3Xper Innoventure Limited has 5 deals on record (4 funding rounds, 1 rights issue), with disclosed funding of ₹125 Cr; the latest was in September 2024.
Deals on record (3 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2024 | Funding round · Series A | ₹25 Cr | Investors: Tube Investments of India Limited |
| Aug 2023 | Funding round · Series A | ₹85.05 Cr | Investors: Tube Investments of India Limited |
| May 2023 | Rights issue | ₹95 Lakh | Investors: Tube Investments of India Limited, Tube Investments of India Limited & S Suresh, Tube Investments of India Limited & RB Selvakumar, an individual |
To see the full deal history of 3Xper Innoventure Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving 3Xper Innoventure Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for 3Xper Innoventure Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
3Xper Innoventure has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AACCZ1929L1ZV | Andhra Pradesh | Active | 26 Oct 2023 |
To see the full GST registrations and return filing status of 3Xper Innoventure Limited, buy the company report.
Recent activity
3Xper Innoventure Limited has 11 board changes on record since 2023: 7 appointments and 4 cessations. The latest: Annamalai Meyyappan ceased to be Additional Director on 27 Jun 2024.
3 earlier events are in the company report.
Frequently asked questions
3Xper Innoventure is an active public limited company based in Chennai, Tamil Nadu, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 12 May 2023 (3+ years old) and is registered under CIN U21001TN2023PLC160370.
3Xper Innoventure has 5 current directors:
- Govindarajan Narayanan - Whole-Time Director
- Mukesh Ahuja - Director
- Vellayan Subbiah - Director
- Annamalai Meyyappan - Individual Subscriber
- Srinivasan Krithika - Individual Subscriber
The latest financial statements of 3Xper Innoventure on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 21 July 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of 3Xper Innoventure is 37AACCZ1929L1ZV, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of 3Xper Innoventure is U21001TN2023PLC160370. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
3Xper Innoventure was incorporated on 12 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Chennai.
3Xper Innoventure has 5 deals on record (4 funding rounds, 1 rights issue), with disclosed funding of ₹125 Cr; the latest was in September 2024.
Annamalai Meyyappan ceased to be Additional Director on 27 Jun 2024. Srinivasan Krithika ceased to be Additional Director on 27 Jun 2024. M A M Arunachalam ceased to be Director on 22 Aug 2023. 3Xper Innoventure has 11 board changes on record in total.
3Xper Innoventure can be reached through the website 3xper.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of 3Xper Innoventure is at Chola Crest C54 – 55 & Super B – 4, Thiru – VI – Ka Industrial Estate Guindy, Chennai, Tamil Nadu, India – 600032.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
